Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Unit of Aorta and Coronary Artery Surgery, E. Meshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russia.
Semin Thromb Hemost. 2020 Nov;46(8):895-907. doi: 10.1055/s-0040-1718399. Epub 2020 Dec 23.
Prompt diagnosis of pulmonary embolism (PE) remains challenging, which often results in a delayed or inappropriate treatment of this life-threatening condition. Mobile thrombus in the right cardiac chambers is a neglected cause of PE. It poses an immediate risk to life and is associated with an unfavorable outcome and high mortality. Thrombus residing in the right atrial appendage (RAA) is an underestimated cause of PE, especially in patients with atrial fibrillation. This article reviews achievements and challenges of detection and management of the right atrial thrombus with emphasis on RAA thrombus. The capabilities of transthoracic and transesophageal echocardiography and advantages of three-dimensional and two-dimensional echocardiography are reviewed. Strengths of cardiac magnetic resonance imaging (CMR), computed tomography, and cardiac ventriculography are summarized. We suggest that a targeted search for RAA thrombus is necessary in high-risk patients with PE and atrial fibrillation using transesophageal echocardiography and/or CMR when available independently on the duration of the disease. High-risk patients may also benefit from transthoracic echocardiography with right parasternal approach. The examination of high-risk patients should involve compression ultrasonography of lower extremity veins along with the above-mentioned technologies. Algorithms for RAA thrombus risk assessment and protocols aimed at identification of patients with RAA thrombosis, who will potentially benefit from treatment, are warranted. The development of treatment protocols specific for the diverse populations of patients with right cardiac thrombosis is important.
肺栓塞(PE)的及时诊断仍然具有挑战性,这往往导致对这种危及生命的疾病的治疗延迟或不恰当。右心腔中的移动血栓是 PE 的一个被忽视的原因。它对生命构成直接威胁,并与不良预后和高死亡率相关。右心耳(RAA)中的血栓是 PE 的一个被低估的原因,尤其是在房颤患者中。本文回顾了检测和管理右心房血栓的成就和挑战,重点是 RAA 血栓。回顾了经胸和经食管超声心动图的能力以及三维和二维超声心动图的优势。总结了心脏磁共振成像(CMR)、计算机断层扫描和心脏心室造影的优势。我们建议,对于 PE 和房颤的高危患者,使用经食管超声心动图和/或 CMR (如果有条件的话),有必要针对 RAA 血栓进行靶向搜索,而无需考虑疾病的持续时间。高危患者也可能受益于经胸超声心动图加右胸骨旁途径。对高危患者的检查应包括下肢静脉的压缩超声检查以及上述技术。需要制定 RAA 血栓风险评估算法和方案,以确定可能受益于治疗的 RAA 血栓患者。为具有右心血栓形成的不同人群制定具体的治疗方案非常重要。